Marja Kreike Selected Research

Ectodermal Dysplasia (Aplasia Cutis Congenita)

9/2015

XEDAR activates the non-canonical NF-κB pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marja Kreike Research Topics

Disease

1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Dermatitis 01/2019
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 11/2018
1	Inflammation (Inflammations) 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2016
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 09/2015
1	Infections 01/2008
1	Necrosis 01/2008

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 11/2018 - 01/2008
2	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 11/2018 - 01/2016
1	Immunoglobulin E (IgE)IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Cysteine Proteases (Cysteine Protease)IBA 11/2018
1	Deubiquitinating EnzymesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	MAP Kinase Kinase 4IBA 01/2018
1	Xedar ReceptorIBA 09/2015
1	LipopolysaccharidesIBA 01/2008
1	NF-kappa B (NF-kB)IBA 01/2008